Phase-Transfer Mediated Heteroaromatic Nucleophilic Substitution: Introduction of a β-Adrenergic Blocking Moiety
-
Serio Duggan, Angelina J.,Grabowski, Edward J. J.,Russ, Warren K.
p. 573 - 575
(2007/10/02)
Certain 3-cyanopyridine intermediates
Novel 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines, their pharmaceutically acceptable salts and their preparation are disclosed. These pyridines are vasodilators having anti-hypertensive activity of rapid onset and extended durati
-
(2008/06/13)
ESTERIFIED-2(3-LOWER-ALKYL-AMINO-PROPOXY)-3-CYANO-PYRIDINES AND DERIVATIVES
Novel cyano substituted (3-loweralkylamino-2-acyl-O-propoxy) pyridines, their pharmaceutically acceptable salts and their preparation are disclosed. The pyridines are vasodilators having antihypertensive activity of rapid onset and extended duration and r
-
(2008/06/13)
2-(3-TERT.BUTYL OR ISOPROPYLAMINO-2-HYDROXYPROPOXY)-3-CYANOPYRIDINES
Novel 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines, their pharmaceutically their preparation are disclosed. These pyridines are vasodilators having anti-hypertensive activity of rapid onset and extended duration and reduced tenden
-
(2008/06/13)
More Articles about upstream products of 60559-92-4